CRMD CorMedix Forecast, Technical & Fundamental Analysis

a developer of medical devices for cardiovascular and kidney diseases

Industry Biotechnology

Get AI intraday signals

CRMD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CRMD
(Try 14 days for Free)

View a ticker or compare two or three

Compare

CRMD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CRMD
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

CRMD is expected to report earnings to fall 60.00% to -1 cents per share on April 01

Q4'24

Est.

$-0.02

Q3'24

Beat

by $0.06

Q2'24

Est.

$-0.25

Q1'24

Beat

by $0.01

Q4'23

Missed

by $0.07

The last earnings report on October 30 showed earnings per share of -5 cents, beating the estimate of -10 cents. With 685.86K shares outstanding, the current market capitalization sits at 518.18M.

A.I. Advisor

published General Information

General Information

a developer of medical devices for cardiovascular and kidney diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Medical Specialties

Address

300 Connell Drive

Phone

+1 908 517-9500

Employees

Web

https://www.cormedix.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
TSLA	463.02	26.79	+6.14%
Tesla
GME	29.44	1.45	+5.18%
GameStop Corp
BTC.X	106029.720000	1731.023400	+1.66%
Bitcoin cryptocurrency
AAPL	251.04	2.91	+1.17%
Apple
SPY	606.79	2.58	+0.43%
SPDR® S&P 500® ETF Trust

CRMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CRMD has been loosely correlated with RLYB. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CRMD jumps, then RLYB could also see price increases.

Ticker / NAME	Correlation To CRMD	1D Price Change %
CRMD	100%	-0.84%
RLYB - CRMD	34% Loosely correlated	-4.63%
SAGE - CRMD	33% Poorly correlated	-0.74%
PGEN - CRMD	32% Poorly correlated	-0.25%
VRDN - CRMD	32% Poorly correlated	+20.67%
ARCT - CRMD	31% Poorly correlated	-5.64%
More